NAT10通过增加N4-乙酰化PTX3 mRNA的稳定性和翻译效率促进类风湿关节炎滑膜侵袭
研究在类风湿关节炎(RA)患者滑膜成纤维细胞(FLS)和滑膜中发现NAT10与ac4C水平升高,NAT10敲低或抑制剂处理可降低RA FLS迁移和侵袭。NAT10抑制在CIA和DTHA小鼠及CIA大鼠中减轻关节炎严重程度。机制上NAT10通过促进N4-乙酰化PTX3 mRNA稳定性和翻译效率调控RA FLS功能,PTX3也调控RA FLS侵袭并与滑膜免疫细胞浸润相关。
要点
- RA患者FLS和滑膜中NAT10与ac4C水平升高,NAT10敲低或抑制剂处理降低RA FLS迁移和侵袭。
- 滑膜NAT10水平升高与多种类型免疫细胞滑膜浸润正相关。
- NAT10抑制在CIA和DTHA小鼠及CIA大鼠中减轻关节炎严重程度,机制涉及PTX3 mRNA稳定性与翻译。
核心结论
- NAT10介导的ac4C修饰在促进类风湿滑膜侵袭和炎症中起重要作用,NAT10可能是治疗RA乃至其他FLS失调相关疾病的潜在靶点。
研究设计与样本
- 研究获取活动期确诊RA患者的FLS,采用western blotting、免疫组化或多重免疫组化检测蛋白表达,Boyden小室检测细胞迁移,ac4C-RIP-seq联合RNA-seq鉴定NAT10潜在靶点,RNA免疫沉淀验证蛋白与mRNA互作。
- 体内实验采用NAT10单倍体不足、抑制剂remodelin或关节腔内注射Adv-NAT10抑制小鼠延迟型超敏关节炎(DTHA)、胶原II诱导关节炎(CIA)及大鼠CIA的关节炎。
主要发现
- RA患者FLS和滑膜中NAT10与ac4C水平升高,NAT10敲低或特异性抑制剂处理降低RA FLS迁移和侵袭。
- 滑膜NAT10水平升高与多种类型免疫细胞滑膜浸润正相关。
- NAT10抑制在CIA和DTHA小鼠及CIA大鼠体内减轻关节炎严重程度。
- 机制上NAT10通过促进N4-乙酰化PTX3 mRNA的稳定性和翻译效率调控RA FLS功能,PTX3也调控RA FLS侵袭并与滑膜免疫细胞浸润相关。
临床怎么用
- 作者认为NAT10可能是治疗RA乃至其他FLS失调相关疾病的潜在靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent studies indicate that N-acetyltransferase 10 (NAT10)-mediated ac4C modification plays unique roles in tumour metastasis and immune infiltration. This study aimed to uncover the role of NAT10-mediated ac4C in fibroblast-like synoviocytes (FLSs) functions and synovial immune cell infiltration in rheumatoid arthritis (RA). METHODS: FLSs were obtained from active established patients with RA. Protein expression was determined by western blotting or immunohistochemistry or multiplexed immunohistochemistry. Cell migration was measured using a Boyden chamber. ac4C-RIP-seq combined with RNA-seq was performed to identify potential targets of NAT10. RNA immunoprecipitation was used to validate the interaction between protein and mRNA. NAT10 haploinsufficiency, inhibitor remodelin or intra-articular Adv-NAT10 was used to suppress arthritis in mice with delayed-type hypersensitivity arthritis (DYHA) and collagen II-induced arthritis (CIA) and rats with CIA. RESULTS: We found elevated levels of NAT10 and ac4C in FLSs and synovium from patients with RA. NAT10 knockdown or specific inhibitor treatment reduced the migration and invasion of RA FLSs. Increased NAT10 level in the synovium was positively correlated with synovial infiltration of multiple types of immune cells. NAT10 inhibition in vivo attenuated the severity of arthritis in mice with CIA and DTHA, and rats with CIA. Mechanistically, we explored that NAT10 regulated RA FLS functions by promoting stability and translation efficiency of N4-acetylated PTX3 mRNA. PTX3 also regulated RA FLS aggression and is associated with synovial immune cell infiltration. CONCLUSION: Our findings uncover the important roles of NAT10-mediated ac4C modification in promoting rheumatoid synovial aggression and inflammation, indicating that NAT10 may be a potential target for the treatment of RA, even other dysregulated FLSs-associated disorders.
引用
- Liu D, Kuang Y, Chen S, et al. NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis. Ann Rheum Dis. 2024. PMID: 38724075. doi:10.1136/ard-2023-225343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。